Index Entries - Covid Index

1151 Results

Title	IS Publication Date
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19	March 22, 2021
SARS-CoV-2 Is an Unrestricted Bioweapon: A Truth Revealed through Uncovering a Large-Scale, Organized Scientific Fraud	October 8, 2020
SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis	August 30, 2021
SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels	September 17, 2020
SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro	March 21, 2022
SARS-CoV-2 re-infection risk in Austria	February 13, 2021
SARS-CoV-2 S1 Protein Persistence in SARS-CoV-2 Negative Post-Vaccination Individuals with Long COVID/ PASC-Like Symptoms	July 12, 2022
SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia	October 28, 2021
SARS-CoV-2 spike mRNA vaccine sequences circulate in blood up to 28 days after COVID-19 vaccination	January 17, 2023
SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term Neurological Complications in post-COVID-19	April 5, 2023
SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Promote a Proinflammatory Activation Profile on Human Dendritic Cells	November 23, 2021
SARS-CoV-2 Spike Protein and Lung Vascular Cells	December 30, 2020
SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines	January 11, 2021
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2	March 31, 2021
SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity	June 11, 2021
SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects
SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19	August 20, 2021
SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly	November 15, 2022
SARS-CoV-2 spike S2 subunit inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells	April 15, 2024
SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia	April 14, 2021
SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents	April 20, 2022
SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of Oncogenesis	December 17, 2023
SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis	April 21, 2022
SARS-CoV-2 vaccine and increased myocarditis mortality risk: A population based comparative study in Japan	December 22, 2022
SARS-CoV-2 Vaccine Breakthrough Surveillance and Case Information Resource	October 27, 2021
SARS-CoV-2 vaccine protection and deaths among US veterans during 2021	November 4, 2021
SARS-CoV-2 variants of concern and variants under investigation in England - Technical briefing 20	August 6, 2021
SARS-CoV-2 variants of concern and variants under investigation in England – Technical briefing 23	September 17, 2021
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls	July 15, 2020
SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells	June 30, 2021
SARS-like WIV1-CoV poised for human emergence	March 14, 2016
Science Committee hearing: Testimony of Dr. Peter Hotez	March 5, 2020
Seasonal UV exposure and vitamin D: Association with the dynamics of COVID-19 transmission in Europe	October 5, 2021
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans	August 4, 2020
Self-Reported Real-World Safety and Reactogenicity of COVID-19 Vaccines: A Vaccine Recipient Survey	March 17, 2021
Self-Selected COVID-19 “Unvaccinated” Cohort Reports Favorable Health Outcomes and Unjustified Discrimination in Global Survey	August 12, 2022
Send This Article to People Who Say “Ivermectin Doesn’t Work for Covid-19”	June 10, 2024
Senior BMJ Editor's commentary on the changing definition of 'vaccine'	January 24, 2022
Sequencing of bivalent Moderna and Pfizer mRNA vaccines reveals nanogram to microgram quantities of expression vector dsDNA per dose	April 9, 2023
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults	September 22, 2022
Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials	September 22, 2022
Serious complications of COVID-19 vaccines: A mini-review	October 30, 2021
Serious harms of the COVID-19 vaccines: a systematic review
Serious Safety Signals and Prediction Features Following COVID-19 mRNA Vaccines Using the Vaccine Adverse Event Reporting System	March 10, 2024
Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland	July 14, 2020
Session 86 of the Corona Investigative Committee	January 7, 2022
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses	August 6, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study	April 5, 2022
Severe Myocarditis in a Female Following mRNA-1273 Vaccine: A Case Report and Review of the Literature	September 18, 2022
Sex-specific differences in myocardial injury incidence after COVID-19 mRNA-1273 booster vaccination	July 20, 2023

Page 18 of 24